Quantification of the neutralization of cytokine biological activity by antibody: The ten-Fold reduction bioassay of interleukin-6 as growth factor

Journal of Interferon and Cytokine Research

Volumn 29, Issue 8, 2009, Pages 421-426

  Grossberg, Sidney E ^a   Casey, Monika ^a   Grossberg, Leslie D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERFERON; INTERLEUKIN 6; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY TITER; BIOASSAY; BIOLOGICAL ACTIVITY; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HYBRIDOMA CELL CULTURE; IMMUNOGENICITY; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; STANDARDIZATION;

ANTIBODIES, BLOCKING; BIOLOGICAL ASSAY; CELL GROWTH PROCESSES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EVALUATION STUDIES AS TOPIC; HUMANS; HYBRIDOMAS; IMMUNITY, CELLULAR; INTERLEUKIN-6; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 68949135122     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0122     Document Type: Review

References (34)

1. Andzhaparidze OG, Ayres JJ, De Maeyer E, Finter N, Friedman R, Grossberg SE, Kramer SM, Laughlin CA, Leibowitz PJ. 1988. WHO expert committee on biological standardization. thirty-eighth report. annex l. standardization of interferons: Report of a WHO informal consultation. World Health Organ Tech Rep 771:37-87
2. Berg K, Billiau A, De Maeyer E, Finter N, Galasso GJ, Grossberg SE, Hilfenhaus J, Kawade Y, de J. Limonta, M., Meager A, Oden EM, Perkins FT, van Ramshorts JD, Vilcek J, Testa D, Trown PW. 1983. WHO expert committee on biological standardization. thirty- third report. annex 1. standardization of interferons. World Health Organ Tech Rep 687:35-60.
3. Billiau A, Dennis P, De Maeyer E, Finter N, Galasso GJ, Grossberg SE, Hilfenhaus J, de J. Limonta, M., Meager A, Oden EM, Petranyi G, Surprenant H, Testa D, Trown PW, Vilcek J, Yamazake S. 1985. WHO expert committee on biological standardization. thirty- fifth report. annex 1. standardization of interferons. World Health Organ Tech Rep 725:28-64.
4. Calam DH, Drozdov SG, Gust ID, Hardegree MC, Lemoine PE, Lyng J, Ofosu FA, Tan I, Hai-jun Z. 1995. World health organization expert committee on biological standardization. forty-fifth report. annex 4 biological substances: International standards and reference reagents. World Health Organ Tech Rep 858:93.
5. Files JG, Hargrove D, Delute L, Cantillon M. 2007. Measured neutralizing titers of IFN-beta neutralizing antibodies (NAbs) can depend on the preparations of IFN-beta used in the assay. J Interferon Cytokine Res 27(8):637-642.
6. Gaines Das RE, Poole S. 1993. The international standard for inter- leukin-6. evaluation in an international collaborative study. J Immunol Methods 160(2):147-153.
7. Grossberg SE, Taylor JL, Siebenlist RE, Jameson P. 1986. Biological and immunological assays of human interferons. In: Rose NR, Friedman R, Fahey JL, eds. Manual of clinical immunology, 3rd ed. Washington, DC: ASM Publishing. pp. 295-299.
8. Grossberg SE, Kawade Y. 1997. The expression of potency of neutralizing antibodies for interferons and other cytokines. Biotherapy 10(1):93-98.
9. Grossberg SE, Kawade Y, Kohase M, Yokoyama H, Finter N. 2001a. The neutralization of interferons by antibody. I. quantitative and theoretical analyses of the neutralization reaction in different bioassay systems. J Interferon Cytokine Res 21(9):729-742.
10. Grossberg SE, Kawade Y, Kohase M, Klein JP. 2001b. The neutralization of interferons by antibody. II. neutralizing antibody unitage and its relationship to bioassay sensitivity: the tenfold reduction unit. J Interferon Cytokine Res 21(9):743-755.
11. Grossberg SE, Kawade Y. 2006. The development and measurement of antibodies to interferon. In: Meager A, ed. The interferons: Characterization and application. Weinheim, Germany: Wiley- VCH Verlag GmbH & Co. pp. 375-399.
12. Grossberg SE, Kawade Y, Grossberg LD. 2009. The neutralization of Interferons by Antibody III. The constant antibody bioassay, a highly sensitive quantitative detector of low antibody levels. J Interferon Cytokine Res 29(2):93-104.
13. Gupta S, Indelicato SR, Jethwa V, Kawabata T, Kelley M, Mire-Sluis AR, Richards SM, Rup B, Shores E, Swanson SJ, Wakshull E. 2007. Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics. J Immunol Methods 321(1-2):1-18.
14. Helle M, Boeije L, Aarden LA. 1988. Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 18(10):1535-1540.
15. Janeway CA, Travers P, Walport J, Shlomchik MJ, eds. 2005. Immuno-biology. 6th ed. New York, NY: Garland Publishing. p 823.
16. Kawade Y. 1980. An analysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer. J Interferon Res 1(1):61-70.
17. Kawade Y, Watanabe Y. 1984. Neutralization of interferon by antibody: Appraisals of methods of determining and expressing the neutralization titer. J Interferon Res 4(4):571-584.
18. Kawade Y, Watanabe Y. 1985. The nature of neutralization reaction between effector protein and monoclonal antibody: a quantitative study of neutralization characteristics of anti-interferon antibodies. Immunology 56(3):489-495.
19. Kawade Y. 1986. Quantitation of neutralization of interferon by antibody. Meth Enzymol 119:558-573.
20. Kawade Y, Finter N, Grossberg SE. 2003. Neutralization of the biological activity of cytokines and other protein effectors by antibody: theoretical formulation of antibody titration curves in relation to antibody affinity. J Immunol Methods 278(1-2):127-144.
21. Lallemand C, Mariete J, Erickson R, Grossberg SE, Roullet E, Lyon- Caen O, Lebon P, Tovey MG. 2008. Quantification of neutralizing antibodies to human type I interferons using division-arrested frozen cells carrying an interferon-regulated reporter-gene. J Interferon Cytokine Res 28:393-404.
22. Lam R, Farrell R, Aziz T, Gibbs E, Giovannoni G, Grossberg S, Oger J. 2008. Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients. J Immunol Methods 336(2):113-118.
23. Morales-Montor J. 2005. The role of the pleiotropic cytokine inter-leukin-6 (IL-6) during disease. MAI 16:21-26.
24. Nakahara H, Nishimoto N. 2006. Anti-interleukin-6 receptor antibody therapy in rheumatic diseases. Endocr Metab Immune Disord Drug Targets 6(4):373-381.
25. Novick D, Eshhar Z, Revel M, Mory Y. 1989. Monoclonal antibodies for affinity purification of IL-6/IFN-fj2 and for neutralization of HGF activity. Hybridoma 8(5):561-567.
26. Ohsugi Y. 2007. Recent advances in IL-6 related to autoimmunity. The Scientist 21(5):s36.
27. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. 1998. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128(2):127-137.
28. Porter S. 2001. Human immune response to recombinant human proteins. J Pharm Sci 90(1):1-11.
29. Pungor E, Jr, Files JG, Gabe JD, Do LT, Foley WP, Gray JL, Nelson JW, Nestaas E, Taylor JL, Grossberg SE. 1998. A novel bioassay for the determination of neutralizing antibodies to IFN-beta1b. J Interferon Cytokine Res 18(12):1025-1030.
30. Redlich PN, Grossberg SE. 1989. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies. J Immunol 143(6):1887-1893.
31. Schellekens H. 2003. The immunogenicity of biopharmaceuticals. Neurology 61(9 Suppl 5):S11-S12.
32. Van Snick J. 1990. Interleukin-6: An overview. Annu Rev Immunol 8:253-278.
33. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24(2):179-189.
34. Wendling D, Racadot E, Wijdenes J. 1993. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 20(2):259-262.